Latest News

Biotronik

CIRSE 2020: New clinical data support use of 4F devices for...

Outcomes of the BIO4AMB trial demonstrated that ambulatory treatment with 4­-French (4F) devices is a valid and safe option for endovascular treatment of lower...

Features

Dialysis access needs to be a priority in the COVID-19 era

Panagiotis M Kitrou and Nicholas Inston discuss the impact of the COVID-19 pandemic on vascular access services. Despite the disruption caused, they are optimistic...
diversity

SIR’s focus on diversity and inclusion: “There needs to be representation...

In response to the global outcry following the murder of an unarmed black American, George Floyd, by police in Minneapolis in late May of...

Videos

NOTE: This video is ONLY available to watch in selected countries and geographies Ripal Gandhi (Miami, USA) outlines his initial experiences with the Caterpillar™ Arterial Embolization Device (BD), a product, which he says is easy to utilize, shows good trackability in tortuous vessels and allows for “very accurate placement”. Gandhi describes the novel device, which consists...
rilling

Bill Rilling

Matthew Johnson

radiology

Ricardo García-Mónaco